Characterization of new mutations in the coding sequence and 5′-untranslated region of the human prostacyclin synthase gene (CYP8A1)

Human Genetics

Volumn 108, Issue 2, 2001, Pages 148-155

  Chevalier, D ^a   Cauffiez, C ^a   Bernard, C ^a   Lo Guidice, J M ^a   Allorge, D ^a   Fazio, F ^a   Ferrari, N ^a   Libersa, C ^a   Lhermitte, M ^a   D'Halluin, J C ^a   Broly, F ^a  

^a France Institut Pasteur de Lille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; INTERLEUKIN 6; PROSTACYCLIN SYNTHASE; TRANSCRIPTION FACTOR SP1;

5' UNTRANSLATED REGION; ALLELE; ARTICLE; BINDING SITE; CAUCASIAN; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEREDITY; HUMAN; HUMAN CELL; LUNG ENDOTHELIUM; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPORTER GENE; VARIABLE NUMBER OF TANDEM REPEAT; VASCULAR DISEASE;

EID: 17744393639     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390000444     Document Type: Article

References (29)

1. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group
2. Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is medicated by Stat3 and Sp1
3. Molecular cloning and expression of prostacyclin synthase from endothelial cells
4. Human cytochrome P450 (CYP) genes: Recommendations for the nomenclature of alleles
5. Human prostacyclin synthase gene and hypertension: The Suita study
6. Transcriptional regulation of the elastin gene by insulin-like growth factor-I involves disruption of Sp1 binding. Evidence for the role of Rb in mediating Sp1 binding in aortic smooth muscle cells
7. Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation
8. Epidermal growth factor stimulation of the human gastrin promoter requires Sp1
9. Molecular cloning and expression of human prostacyclin synthase
10. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin
11. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls
12. Organization of the human prostacyclin synthase gene
13. Nonsense mutation of prostacyclin synthase gene in a family
14. Arachidonic acid metabolism
15. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
16. Functional synergy between the transcription factor Sp1 and the estrogen receptor
17. Pathology and pathophysiology of primary pulmonary hypertension
18. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions
19. Prostacyclin synthase active sites. Identification by molecular modeling-guided site-directed mutagenesis
20. Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter
21. Update: Genetic polymorphism of drug metabolizing enzymes in humans
22. A concept for the mechanism of prostacyclin and thromboxane A2 biosynthesis
23. Spectral evidence for the cytochrome P450 nature of prostacyclin synthetase
24. Pharmacodynamic profile of prostacyclin
25. "Suicide" inactivation of prostaglandin I2 synthase: Characterization of mechanism-based inactivation with isolated enzyme and endothelial cells
26. Human gene encoding prostacyclin synthase (PTGIS): Genomic organization, chromosomal localization, and promoter activity
27. Sp1 is a critical factor for the monocytic specific expression of human CD14
28. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite